Published in Transl Androl Urol on January 01, 2012
Computational analysis of siRNA recognition by the Ago2 PAZ domain and identification of the determinants of RNA-induced gene silencing. PLoS One (2013) 0.80
Micro-RNAs, next-generation molecular markers in male infertility field. Transl Androl Urol (2012) 0.77
Small activating RNA binds to the genomic target site in a seed-region-dependent manner. Nucleic Acids Res (2016) 0.76
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
Hallmarks of cancer: the next generation. Cell (2011) 140.01
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature (1998) 72.56
A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A (2006) 40.09
c-Myc-regulated microRNAs modulate E2F1 expression. Nature (2005) 31.81
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A (2004) 28.29
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol (2008) 24.27
miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A (2005) 21.51
A microRNA component of the p53 tumour suppressor network. Nature (2007) 19.25
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature (2010) 13.82
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology (2007) 13.20
Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev (2002) 10.71
Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol (2008) 10.42
Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes. Nature (2008) 10.11
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature (2010) 10.09
MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature (2008) 9.83
MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell (2009) 8.14
Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR. Proc Natl Acad Sci U S A (2007) 7.93
Modulation of microRNA processing by p53. Nature (2009) 7.88
MIWI2 is essential for spermatogenesis and repression of transposons in the mouse male germline. Dev Cell (2007) 7.66
Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer. Science (2008) 7.59
E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell (2008) 7.56
Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet (2006) 7.53
Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem (2007) 7.46
Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. Cell (2011) 7.02
MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A (2008) 6.38
Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat Biotechnol (2006) 6.30
miwi, a murine homolog of piwi, encodes a cytoplasmic protein essential for spermatogenesis. Dev Cell (2002) 5.85
The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med (2008) 5.74
PIWI-interacting small RNAs: the vanguard of genome defence. Nat Rev Mol Cell Biol (2011) 5.59
Mili, a mammalian member of piwi family gene, is essential for spermatogenesis. Development (2004) 5.47
MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol (2008) 5.21
p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci U S A (2009) 5.05
Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. Nat Chem Biol (2007) 5.05
Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci U S A (2006) 4.90
Non-coding RNAs: the architects of eukaryotic complexity. EMBO Rep (2001) 4.74
miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell (2009) 4.48
Biogenesis and germline functions of piRNAs. Development (2007) 4.37
MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One (2006) 4.29
Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal (2010) 4.15
miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci U S A (2009) 4.15
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. Oncogene (2008) 4.11
miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell (2010) 4.07
An epigenetic activation role of Piwi and a Piwi-associated piRNA in Drosophila melanogaster. Nature (2007) 3.86
RNA interference in the clinic: challenges and future directions. Nat Rev Cancer (2010) 3.43
miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res (2008) 3.19
Identification of novel microRNA targets based on microRNA signatures in bladder cancer. Int J Cancer (2009) 3.15
Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Mol Ther (2009) 2.92
Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res (2010) 2.82
MicroRNA biogenesis is required for mouse primordial germ cell development and spermatogenesis. PLoS One (2008) 2.82
miR-449a targets HDAC-1 and induces growth arrest in prostate cancer. Oncogene (2009) 2.61
miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer (2010) 2.51
Retracted FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer. J Clin Invest (2011) 2.44
Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway. Genes Dev (2010) 2.37
Upregulation of Cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Res (2011) 1.84
RNAa is conserved in mammalian cells. PLoS One (2010) 1.81
The SOX2 response program in glioblastoma multiforme: an integrated ChIP-seq, expression microarray, and microRNA analysis. BMC Genomics (2011) 1.79
Negative regulation of the tumor suppressor p53 gene by microRNAs. Oncogene (2010) 1.78
DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer. Oncogene (2011) 1.76
Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer. Oncogene (2011) 1.69
Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats. Int J Impot Res (2003) 1.68
Gene networks and microRNAs implicated in aggressive prostate cancer. Cancer Res (2009) 1.68
Efficient regulation of VEGF expression by promoter-targeted lentiviral shRNAs based on epigenetic mechanism: a novel example of epigenetherapy. Circ Res (2009) 1.55
Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration. Cancer Res (2010) 1.54
Altered microRNA expression in patients with non-obstructive azoospermia. Reprod Biol Endocrinol (2009) 1.51
Improving erectile function by silencing phosphodiesterase-5. J Urol (2005) 1.43
Expression of the stem cell self-renewal gene Hiwi and risk of tumour-related death in patients with soft-tissue sarcoma. Oncogene (2006) 1.40
Down-regulation of signal transducer and activator of transcription 3 expression using vector-based small interfering RNAs suppresses growth of human prostate tumor in vivo. Clin Cancer Res (2005) 1.40
EphB4 receptor tyrosine kinase is expressed in bladder cancer and provides signals for cell survival. Oncogene (2006) 1.39
Antitumor effect of dsRNA-induced p21(WAF1/CIP1) gene activation in human bladder cancer cells. Mol Cancer Ther (2008) 1.39
Small RNA and transcriptional upregulation. Wiley Interdiscip Rev RNA (2011) 1.36
MicroRNA145 targets BNIP3 and suppresses prostate cancer progression. Cancer Res (2010) 1.26
Intravesical administration of small interfering RNA targeting PLK-1 successfully prevents the growth of bladder cancer. J Clin Invest (2005) 1.23
PTEN gene and integrin signaling in cancer. J Natl Cancer Inst (1999) 1.19
Overexpression of miR-21 promotes an in vitro metastatic phenotype by targeting the tumor suppressor RHOB. Mol Cancer Res (2010) 1.18
Piwis and piwi-interacting RNAs in the epigenetics of cancer. J Cell Biochem (2012) 1.14
Altered profile of seminal plasma microRNAs in the molecular diagnosis of male infertility. Clin Chem (2011) 1.14
Targeting ECM-integrin interaction with liposome-encapsulated small interfering RNAs inhibits the growth of human prostate cancer in a bone xenograft imaging model. Mol Ther (2005) 1.07
Genetic variants in Piwi-interacting RNA pathway genes confer susceptibility to spermatogenic failure in a Chinese population. Hum Reprod (2010) 1.05
Up-regulation of p21WAF1/Cip1 by saRNA induces G1-phase arrest and apoptosis in T24 human bladder cancer cells. Cancer Lett (2008) 1.03
Antisense and short hairpin RNA (shRNA) constructs targeting PIN (Protein Inhibitor of NOS) ameliorate aging-related erectile dysfunction in the rat. J Sex Med (2007) 1.01
Comparative profiling of genes and miRNAs expressed in the newborn, young adult, and aged human epididymides. Acta Biochim Biophys Sin (Shanghai) (2010) 0.95
Double stranded-RNA-mediated activation of P21 gene induced apoptosis and cell cycle arrest in renal cell carcinoma. Int J Cancer (2009) 0.94
Knockdown of survivin expression by siRNAs enhances chemosensitivity of prostate cancer cells and attenuates its tumorigenicity. Acta Biochim Biophys Sin (Shanghai) (2009) 0.93
Up-regulation of VEGF by small activator RNA in human corpus cavernosum smooth muscle cells. J Sex Med (2011) 0.91
Up-regulation of E-cadherin by small activating RNA inhibits cell invasion and migration in 5637 human bladder cancer cells. Biochem Biophys Res Commun (2008) 0.91
Combined gene expression profiling and RNAi screening in clear cell renal cell carcinoma identify PLK1 and other therapeutic kinase targets. Cancer Res (2011) 0.90
Suppression of migration and invasion of PC3 prostate cancer cell line via activating E-cadherin expression by small activating RNA. Cancer Invest (2010) 0.87
Effect of small interfering RNA targeting survivin gene on biological behaviour of bladder cancer. Chin Med J (Engl) (2006) 0.86
Suppression of SOCS3 increases susceptibility of renal cell carcinoma to interferon-α. Cancer Sci (2010) 0.84
Polymorphisms in microRNA targets: a source of new molecular markers for male reproduction. Asian J Androl (2011) 0.78
The effect of antisense Bcl-2 oligonucleotides on Bcl-2 protein expression and apoptosis in human bladder transitional cell carcinoma. J Urol (2001) 0.78
Synergistic effect of survivin-specific small interfering RNA and topotecan in renal cancer cells: topotecan enhances liposome-mediated transfection by increasing cellular uptake. Int J Oncol (2007) 0.78
[Impact of rAd5-shRNA- PDE5A3 on cGMP in the smooth muscle cells of human corpus cavernosum]. Zhonghua Nan Ke Xue (2009) 0.77
[Small interfering RNA inhibits the expression of connexin43 in the human corpus cavernosum penis smooth muscle cells]. Zhonghua Nan Ke Xue (2007) 0.76
[Phosphodiesterase type 5 siRNA increases cGMP in the smooth muscle cells of human corpus cavernosum]. Zhonghua Nan Ke Xue (2006) 0.75
MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A (2008) 6.38
Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome. J Cereb Blood Flow Metab (2009) 2.87
Upregulation of Cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Res (2011) 1.84
RNAa is conserved in mammalian cells. PLoS One (2010) 1.81
Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway. Clin Cancer Res (2006) 1.73
Intravesical delivery of small activating RNA formulated into lipid nanoparticles inhibits orthotopic bladder tumor growth. Cancer Res (2012) 1.65
Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration. Cancer Res (2010) 1.54
miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells. Oncotarget (2010) 1.53
The E-cadherin -160 C/A polymorphism and prostate cancer risk in white and black American men. J Urol (2006) 1.43
Antitumor effect of dsRNA-induced p21(WAF1/CIP1) gene activation in human bladder cancer cells. Mol Cancer Ther (2008) 1.39
Small RNA and transcriptional upregulation. Wiley Interdiscip Rev RNA (2011) 1.36
Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer. Clin Cancer Res (2005) 1.25
Multigene methylation analysis for detection and staging of prostate cancer. Clin Cancer Res (2005) 1.18
Ago1 Interacts with RNA polymerase II and binds to the promoters of actively transcribed genes in human cancer cells. PLoS Genet (2013) 1.18
Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma. Cancer (2006) 1.17
Effects of transplantation of adipose tissue-derived stem cells on prostate tumor. Prostate (2010) 1.15
Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clin Cancer Res (2005) 1.14
A component of green tea, (-)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins. Biochem Biophys Res Commun (2007) 1.09
Functional Loss of the gamma-catenin gene through epigenetic and genetic pathways in human prostate cancer. Cancer Res (2005) 1.09
Defining features and exploring chemical modifications to manipulate RNAa activity. Curr Pharm Biotechnol (2010) 1.09
Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer. Int J Cancer (2005) 1.06
CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer. Cancer Res (2004) 1.05
CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer. Cancer (2005) 1.00
Epigenetic inactivation of the dioxin-responsive cytochrome P4501A1 gene in human prostate cancer. Cancer Res (2006) 0.96
Targeted induction of endogenous NKX3-1 by small activating RNA inhibits prostate tumor growth. Prostate (2013) 0.95
Targeted p21WAF1/CIP1 activation by RNAa inhibits hepatocellular carcinoma cells. Nucleic Acid Ther (2012) 0.94
Chromatin changes on the GSTP1 promoter associated with its inactivation in prostate cancer. Mol Carcinog (2007) 0.94
miR-663 induces castration-resistant prostate cancer transformation and predicts clinical recurrence. J Cell Physiol (2014) 0.93
Induction of NANOG expression by targeting promoter sequence with small activating RNA antagonizes retinoic acid-induced differentiation. Biochem J (2012) 0.93
Comparison of open surgery versus retroperitoneoscopic approach to chyluria. J Urol (2003) 0.92
Identification of an aberrant cell line among human adipose tissue-derived stem cell isolates. Differentiation (2008) 0.91
Formulation of Small Activating RNA Into Lipidoid Nanoparticles Inhibits Xenograft Prostate Tumor Growth by Inducing p21 Expression. Mol Ther Nucleic Acids (2012) 0.91
Retroperitoneal laparoscopic nephron-sparing surgery for renal tumors: report of 32 cases. Urology (2005) 0.89
miRNA goes nuclear. RNA Biol (2012) 0.87
An orthotopic bladder tumor model and the evaluation of intravesical saRNA treatment. J Vis Exp (2012) 0.87
Relationship between glucocorticoid receptor signal pathway and androgen-independent prostate cancer. Urol Int (2008) 0.86
Retroperitoneoscopic subcapsular nephrectomy for infective nonfunctioning kidney with dense perinephric adhesions. BJU Int (2004) 0.84
Comparison of retroperitoneoscopic nephrectomy versus open approaches to nonfunctioning tuberculous kidneys: a report of 44 cases. J Urol (2005) 0.84
CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer. Mol Carcinog (2002) 0.84
MicroRNA regulation of neuron-like differentiation of adipose tissue-derived stem cells. Differentiation (2009) 0.82
Association between a C/A single nucleotide polymorphism of the E-cadherin gene promoter and transitional cell carcinoma of the bladder. J Urol (2003) 0.81
Adaptation and clonal selection models of castration-resistant prostate cancer: current perspective. Int J Urol (2012) 0.80
Identification of small activating RNAs that enhance endogenous OCT4 expression in human mesenchymal stem cells. Stem Cells Dev (2014) 0.80
saRNA guided iNOS up-regulation improves erectile function of diabetic rats. J Urol (2013) 0.79
RNAa in action: from the exception to the norm. RNA Biol (2014) 0.78
Kidney gene database: a curated and integrated database of genes involved in kidney disease. J Urol (2004) 0.78
Inducing gene expression by targeting promoter sequences using small activating RNAs. J Biol Methods (2015) 0.77
Transforming growth factor-beta(s) and their receptors in aging rat prostate. Biochem Biophys Res Commun (2002) 0.75